What could fix cancer clinical trials’ longstanding diversity problem?
When clinical trials lack diversity, that makes it difficult to understand how study findings apply to the population groups underrepresented in the trial.
There’s a diversity problem in cancer clinical trials, and few know this better than Stephanie Walker. When she was diagnosed with stage 4 metastatic breast cancer, Walker said there was no one to help her figure out the system, not even a nurse or patient navigator.
“I was told, ‘Well, you’re a nurse, you know you got this, you know it all,”’ said Walker, a hospice nurse for over 40 years and a patient advocate. “Technically, I didn’t.”
What's Your Reaction?
